You just read:

Water Street's Partnership with Leading Medical Products Company Leads to FDA Approval and Commercial Launch of Clindamycin in 0.9% Sodium Chloride Injection

News provided by

Water Street Healthcare Partners

Jun 07, 2017, 11:30 ET